Monday, July 16, 2018
 
 
Company News: Page (1) of 1 - 04/03/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
European Commission Approves Expanded Indication For Amgen's XGEVAŽ (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
This Approval was Based on the Largest International Trial Ever Conducted for the Prevention of Skeletal-Related Events in Multiple Myeloma Patients
(April 03, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Database,Business Issues,Administration,Legal,Other,Management,Sales,Sales,USA,IT (Information Technology),Security,Medicine,Disease,Surgery,
Related Sites: DMN Newswire ,   IBN - Business ,   IBN - ProductivityApps ,   IBN - Security ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Personal Care Home Consultant Lynn Marting Helps Families Find the Right Facility for Aging Loved Ones
  • Mount Sinai Health System and Arena Address AI-Driven Hiring for Healthcare at Leading Industry Conference
  • Connected Health Devices: Global Market Forecast to 2023 - CAGR to Grow at 21.1%, Driven by the Increasing Adoption of IT in Healthcare
  • Global Special Purpose Needles Industry
  • Gregory J. Paul, MA Honored as a Top Executive by Strathmore's Who's Who Worldwide Publication

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Global Rice Bran Oil Market Professional Survey Report, 2018 by Radiant Insights
  • RiMO Therapeutics Announces Enrollment of the First Patient in Phase 1 Study of RiMO-301 With Radiation in Advanced Tumors
  • Patient Advocate Foundation Receives Grant to Advance Cost of Care Conversations between Patients and Health Care Providers
  • CytRx Corporation to Present at the Singular Research Summer Solstice 2018 Conference
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines